Scientific Advisory Panel (SAP)
Dr. Sierra’s career has spanned academia, industry and government, including his role as Director of the Division of Aging Biology at the NIA/NIH, from 2006 to 2019, where he was an important contributor to the development of the concept of Geroscience, including the creation and leadership of the trans-NIH Geroscience Interest Group (GSIG). Before joining Hevolution in 2022, he was Director of Geroscience for Inspire.
Dr. Sierra holds a Ph.D. in Biochemistry and Molecular Biology from the University of Florida and was an Assistant Professor at the Medical College of Pennsylvania, and an Associate Professor at the Lankenau Institute for Medical Research in Pennsylvania.
Dr. Felipe Sierra
Distinguished Professor, Departments of Biochemistry and Physiology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore
Director, Centre for Healthy Longevity, National University Health System (NUHS) Singapore
Programme Director, Healthy Longevity Translational Research Programme, Adjunct Professor, Leonard Davis School of Gerontology, University of Southern California, Los Angeles, United States
Affiliate Faculty, Department of Biochemistry, University of Washington, Seattle, Washington, United States
Brian Kennedy, PhD is a Distinguished Professor in Biochemistry and Physiology at the Yong Loo Lin School of Medicine at National University Singapore (NUS) and serves as Director of (1) the Centre for Healthy Longevity at the National University Health System in Singapore, (2) the NUS Medicine Healthy Longevity Translational Research Programme, and (3) the Asia Centre for Reproductive Longevity and Equality at the NUS School of Medicine.
Prof. Kennedy was formerly President and CEO of the Buck Institute for Research on Aging and served as a professor there through 2020. He has an adjunct appointment at the Department of Biochemistry at the University of Washington, where he was a faculty member from 2001 to 2010. Additionally, Prof. Kennedy serves as a Co-Editor-In-Chief at Aging Cell, a peer-reviewed, open access scientific journal. Prof. Kennedy also served as Visiting Professor at the Aging Research Institute at Guangdong Medical College in China from 2009 to 2014.
Prof. Kennedy’s Ph.D. was performed in the laboratory of Leonard Guarente at the Massachusetts Institute of Technology, where he published the first paper linking Sirtuins to aging.
Prof. Brian Kennedy
Professor at the Faculty of Medicine of the University of Paris Cité, France
Director of the research team "Metabolism, Cancer and Immunity" of the French Medical Research Council (INSERM), France
Director of the Metabolomics and Cell Biology platforms of the Gustave Roussy Comprehensive Cancer Center, France
Hospital Practitioner at the Hôpital Européen George Pompidou, Paris, France
Guido Kroemer, MD, PhD, is Professor at the Faculty of Medicine of the University of Paris Cité, Director of the research team "Metabolism, Cancer and Immunity"; of the French Medical Research Council (INSERM), Director of the Metabolomics and Cell Biology platforms of the Gustave Roussy Comprehensive Cancer Center, and Hospital Practitioner at the Hôpital Européen George Pompidou, Paris, France. Kroemer is the director of LabEx Immuno-Oncology, a research consortium, and President of the European Academy of Tumor Immunology (EATI).
Prior to joining INSERM, Prof. Kroemer was Senior Scientist of the European Community at the Spanish National Research Council (CSIC), at the National Center of Molecular Biology and at the National Center of Biotechnology. He was the Director of the Paris Alliance of Cancer Research Institutes (PACRI) from 2013 to 2017. He was Foreign Adjunct Professor at the Karolinska Institute, Stockholm, Sweden (2016-2021), Honorary Professor at the Suzhou Center of Systems Medicine, Chinese Academy of Medical Sciences (2016-2019), and held the Oon Chiew Seng Distinguished Professorship of the National University of Singapore (2019).
Prof. Kroemer did his post-doctoral training at the Collège de France, Nogent-sur-Marne, and at the University of Innsbruck, Austria, after receiving his PhD/MD degree at the same University in 1985, and also holds a PhD in Molecular Biology from Autonomous University of Madrid.
Prof. Kroemer is the founding Editor-in-Chief of six journals, including Cell Death & Disease (Nature Publishing Group, Springer), and is Editor-in-Chief of Seminars in Immunology (Elsevier).
Prof. Guido Kroemer
Oon Chiew Seng Professor in Medicine, Healthy Ageing and Dementia Research, Singapore
Co-Director Centre for Healthy Longevity, National University of Singapore, Singapore
Professor of Gerontology, Vrije Universiteit Amsterdam, The Netherlands
Andrea Maier, MD, PhD is Professor of Gerontology and Co-Director of the Centre for Healthy Longevity at the National University of Singapore and Professor of Gerontology at the Vrije Universiteit Amsterdam, The Netherlands. She was previously Divisional Director of Medicine and Community Care at the Royal Melbourne Hospital and Professor of Medicine and Aged Care at the University of Melbourne, Australia. Before that she served as head of Geriatrics at the VU University Medical Center in Amsterdam.
Prof. Maier’s research focuses on unravelling the mechanisms of ageing and age-related diseases in humans. During the last decade she has conducted multiple international observational cohort studies and intervention trials, and has published more than 360 peer-reviewed articles, achieving an H index of 66, spearheading the contributions of a global, multidisciplinary research group that she founded, “@Age.”
Prof. Maier is a frequent guest on radio and television programs to disseminate aging research and an invited member of several international academic and health policy committees, including the World Health Organization (WHO). She is the Founding President of the Healthy Longevity Medicine Society and serves as selected Member of the Royal Holland Society of Sciences and Humanities. She is a Fellow of the Royal Australasian College of Physicians (FRACP), graduated in Medicine (MD) from the University of Lübeck (Germany) and is registered in the Netherlands as Specialist in Internal Medicine and Geriatrics.
Prof. Andrea Maier
Director of the Institute on the Biology of Aging & Metabolism (iBAM) at the University of Minnesota, United States
Laura Niedernhofer, MD, PhD is the director of the Institute on the Biology of Aging Metabolism (iBAM) at the University of Minnesota. Prof. Niedernhofer’s expertise is in how cellular senescence is regulated as well as the role of DNA repair during aging.
Prior to joining the University of Minnesota, Prof. Niedernhofer was at the Scripps Research Institute in Florida. She trained at the Massachusetts Institute of Technology, Duke University, Vanderbilt University, and Erasmus Medical Center in the Netherlands. She was awarded a Glenn Award for Aging Research and the Vincent Cristofolo Rising Star Award in Aging Research from the American Federation for Aging Research (AFAR)
Prof. Laura Niedernhofer
Director, Broad Stem Cell Research Center, University of California, Los Angeles (UCLA), United States
Professor, Neurology and Molecular, Cell, and Developmental Biology, UCLA, United States
Thomas Rando, MD, PhD is the Director of the Broad Stem Cell Research Center at the University of California, Los Angeles (UCLA). He is also a Professor of Neurology and Molecular, Cell, and Developmental Biology. Formerly, he was a Professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. In addition, he was the Director of the Glenn Laboratories for the Biology of Aging at Stanford University and the Deputy Director of the Stanford Center on Longevity, also at Stanford University. Additionally, he served as the Chief of Neurology and Director of the Rehabilitation Research and Development Center of Excellence at the Veterans Affairs Palo Alto Health Care System.
Prof. Rando received the distinguished US National Institute on Aging (NIA) Director’s Pioneer Award and a US National Institutes of Health (NIH) Transformative R01 based on his work in stem cell biology and the biology of aging. He has received numerous other awards, including a Paul Beeson Physician Faculty Scholar in Aging, a Senior Scholar Award from the Ellison Medical Foundation, and a “Breakthroughs in Gerontology” Award from the American Federation for Aging Research. He has served as a member of the National Advisory Council for the NIA.
Prof. Rando is a Fellow of the American Association for the Advancement of Science, a Senior Visiting Fellow at the Institute for Advanced Study at the Hong Kong University of Science and Technology, an Elected Member of both the US National Academy of Medicine and the American Academy of Arts and Sciences.
Prof. Thomas Rando